These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3150693)

  • 1. Lithium combined with haloperidol in schizophrenic patients.
    Lerner Y; Mintzer Y; Schestatzky M
    Br J Psychiatry; 1988 Sep; 153():359-62. PubMed ID: 3150693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study.
    Biederman J; Lerner Y; Belmaker RH
    Arch Gen Psychiatry; 1979 Mar; 36(3):327-33. PubMed ID: 369472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.
    Wilson WH
    Psychopharmacology (Berl); 1993; 111(3):359-66. PubMed ID: 7870975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful combined neuroleptic and lithium treatment of a chronic schizophrenic patient with recurrent aggressive behavior].
    Cabrera JF; Körner W; Müller-Oerlinghausen B
    Nervenarzt; 1986 Jun; 57(6):366-9. PubMed ID: 3736728
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania.
    Garfinkel PE; Stancer HC; Persad E
    J Affect Disord; 1980 Dec; 2(4):279-88. PubMed ID: 6450787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
    Kramer MS; Vogel WH; DiJohnson C; Dewey DA; Sheves P; Cavicchia S; Little P; Schmidt R; Kimes I
    Arch Gen Psychiatry; 1989 Oct; 46(10):922-8. PubMed ID: 2679483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
    Kahn EM; Schulz SC; Perel JM; Alexander JE
    J Clin Psychopharmacol; 1990 Feb; 10(1):54-7. PubMed ID: 2106534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium prevents adaptation of brain dopamine systems to haloperidol in schizophrenic patients.
    Sternberg DE; Bowers MB; Heninger GR; Charney DS
    Psychiatry Res; 1983 Oct; 10(2):79-86. PubMed ID: 6581492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind trial of lithium carbonate and haloperidol in Huntington's chorea.
    Leonard DP; Kidson MA; Brown JG; Shannon PJ; Taryan S
    Aust N Z J Psychiatry; 1975 Jun; 9(2):115-8. PubMed ID: 125578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium addition to neuroleptic treatment in chronic schizophrenia: a randomized, double-blind, placebo-controlled, cross-over study.
    Terao T; Oga T; Nozaki S; Ohta A; Ohtsubo Y; Yamamoto S; Zamami M; Okada M
    Acta Psychiatr Scand; 1995 Sep; 92(3):220-4. PubMed ID: 7484202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
    Klein E; Bental E; Lerer B; Belmaker RH
    Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse in patients with shifting RDC diagnoses treated with lithium alone.
    Glazer WM; Sheard MH
    J Clin Psychiatry; 1982 Apr; 43(4):134-6. PubMed ID: 7068543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.
    Campbell M; Small AM; Green WH; Jennings SJ; Perry R; Bennett WG; Anderson L
    Arch Gen Psychiatry; 1984 Jul; 41(7):650-6. PubMed ID: 6428371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Wu GY
    Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
    Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H
    BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of supidimide in schizophrenic inpatients undergoing neuroleptic maintenance therapy with haloperidol.
    Rapisarda V; Aguglia E; Poma A
    Eur J Clin Pharmacol; 1982; 22(3):217-23. PubMed ID: 7049709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium carbonate in chronic schizophrenia--a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients.
    Collins PJ; Larkin EP; Shubsachs AP
    Acta Psychiatr Scand; 1991 Aug; 84(2):150-4. PubMed ID: 1683094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN; Korpi ER; Kirch DG
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.